sulfinpyrazone has been researched along with Adenocarcinoma in 1 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chow, S | 1 |
| Roscoe, J | 1 |
| Cattran, DC | 1 |
1 other study available for sulfinpyrazone and Adenocarcinoma
| Article | Year |
|---|---|
Plasmapheresis and antiplatelet agents in the treatment of the hemolytic uremic syndrome secondary to mitomycin.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Arginine; Argininosuccinic Ac | 1986 |